Karl Herrup

Active 1973–2025

107
Papers
28,552
Citations
76
h-index
98
i10-index

Citations

Citations per year for Karl Herrup1974: 2 citations1975: 6 citations1976: 7 citations1977: 14 citations1978: 8 citations1979: 9 citations1980: 13 citations1981: 7 citations1982: 12 citations1983: 15 citations1984: 4 citations1985: 13 citations1986: 12 citations1987: 28 citations1988: 24 citations1989: 22 citations1990: 16 citations1991: 33 citations1992: 57 citations1993: 92 citations1994: 112 citations1995: 131 citations1996: 214 citations1997: 197 citations1998: 220 citations1999: 231 citations2000: 248 citations2001: 261 citations2002: 227 citations2003: 241 citations2004: 230 citations2005: 221 citations2006: 278 citations2007: 217 citations2008: 200 citations2009: 204 citations2010: 171 citations2011: 196 citations2012: 200 citations2013: 164 citations2014: 171 citations2015: 209 citations2016: 285 citations2017: 311 citations2018: 303 citations2019: 792 citations2020: 932 citations2021: 948 citations2022: 793 citations2023: 598 citations2024: 827 citations2025: 431 citations2026: 16 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,678 citing papers, 31.5% of this breakdownChina: 1,261 citing papers, 8.5% of this breakdownUnited Kingdom: 939 citing papers, 6.3% of this breakdownGermany: 879 citing papers, 5.9% of this breakdownItaly: 620 citing papers, 4.2% of this breakdownCanada: 578 citing papers, 3.9% of this breakdownJapan: 510 citing papers, 3.4% of this breakdownFrance: 467 citing papers, 3.1% of this breakdownAustralia: 419 citing papers, 2.8% of this breakdownSpain: 364 citing papers, 2.5% of this breakdownNetherlands: 353 citing papers, 2.4% of this breakdownSwitzerland: 292 citing papers, 2% of this breakdown
0%31.5%Other 23.5%

Fields

  • Medicine36.8%
  • Biochemistry, Genetics and Molecular Biology27.3%
  • Neuroscience24.5%
  • Immunology and Microbiology7.2%
  • Agricultural and Biological Sciences0.7%
  • Nursing0.7%
  • Other2.8%

Topics

  • Alzheimer's disease research and treatments8.6%
  • Neuroinflammation and Neurodegeneration Mechanisms6.2%
  • Neuroscience and Neuropharmacology Research2.9%
  • Neurogenesis and neuroplasticity mechanisms2.6%
  • Tryptophan and brain disorders2.5%
  • Cancer-related Molecular Pathways1.7%
  • Other75.5%

Coauthors

All papers

Open in search
  1. Neuroinflammation in Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Olga Garaschuk, Erik Boddeke, Charles A. Dinarello, John C.S. Breitner, Greg M. Cole, Douglas T. Golenbock, Markus P. Kummer - The Lancet Neurology 2015 cited by 6,102

  2. RAG-1-deficient mice have no mature B and T lymphocytes

    Authors: , , , , , - Cell 1992 cited by 2,935

  3. The case for rejecting the amyloid cascade hypothesis

    Authors: - Nature Neuroscience 2015 cited by 760

  4. Age-related hyperinsulinemia leads to insulin resistance in neurons and cell-cycle-induced senescence

    Authors: , , , , , , , , - Nature Neuroscience 2019 cited by 169

  5. The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elı́as Campo, Enrique Carrillo de Santa Pau, Lisa H. Chadwick, Kui Ming Chan, Wei Chen, Tom H. Cheung, Luca Chiapperino, Nak Hyen Choi, Ho‐Ryun Chung, Laura Clarke, Joseph M. Connors, Philippe Cronet, John Danesh, Manolis Dermitzakis, Gerard Drewes, Pawel Durek, Stephanie O. M. Dyke, Tomasz Dyląg, Connie J. Eaves, Peter Ebert, Roland Eils, Jürgen Eils, Catherine Ennis, Tariq Enver, Elise A. Feingold, Bärbel Felder, Anne C. Ferguson‐Smith, Jude Fitzgibbon, Paul Flicek, Roger Foo, Peter Fraser, Mattia Frontini, Eileen E. M. Furlong, Sitanshu Gakkhar, Nina Gasparoni, Gilles Gasparoni, Daniel H. Geschwind, Petar Glažar, Thomas Graf, Frank Grosveld, Xin‐Yuan Guan, Roderic Guigó, Marta Gut, Alf Hamann, Bok-Ghee Han, R. Alan Harris, Simon Heath, Kristian Helin, Jan G. Hengstler, Alireza Heravi‐Moussavi, Karl Herrup, Steven Hill, Jason A. Hilton, Benjamin C. Hitz, Bernhard Horsthemke, Ming Hu, Jooyeon Hwang, Nancy Y. Ip, Takashi Ito, Biola M. Javierre, Sasa Jenko, Thomas Jenuwein, Yann Joly, Steven J.M. Jones, Yae Kanai, Hee Gyung Kang, Aly Karsan, Alexandra K. Kiemer, Song Cheol Kim, Bong-Jo Kim and 130 more - Cell 2016 cited by 566

  6. Accumulation of Cytoplasmic DNA Due to ATM Deficiency Activates the Microglial Viral Response System with Neurotoxic Consequences

    Authors: , , - Journal of Neuroscience 2019 cited by 137

  7. The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes

    Authors: , , , , , , , , , , , - Journal of Alzheimer s Disease 2023 cited by 53

  8. Cortical development: Layers of complexity

    Authors: , - Current Biology 1997 cited by 81

  9. Lecanemab and Donanemab as Therapies for Alzheimer's Disease: An Illustrated Perspective on the Data

    Authors: , , - eNeuro 2024 cited by 78

  10. ATM loss disrupts the autophagy-lysosomal pathway

    Authors: , , , , , , , , - Autophagy 2020 cited by 77

  11. DNA damage in the oligodendrocyte lineage and its role in brain aging

    Authors: , - Mechanisms of Ageing and Development 2016 cited by 111

  12. Apolipoprotein E ε4 Mediates Myelin Breakdown by Targeting Oligodendrocytes in Sporadic Alzheimer Disease

    Authors: , , , , , - Journal of Neuropathology & Experimental Neurology 2022 cited by 33

  13. ATM is activated by ATP depletion and modulates mitochondrial function through NRF1

    Authors: , , , , , - The Journal of Cell Biology 2019 cited by 82

  14. Deletion of ERK2 Mitogen-Activated Protein Kinase Identifies Its Key Roles in Cortical Neurogenesis and Cognitive Function

    Authors: , , , , , , , - Journal of Neuroscience 2008 cited by 272

  15. Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit

    Authors: , , , , , , , , , , , , - Ageing Research Reviews 2024 cited by 36

  16. The proteinopenia hypothesis: Loss of Aβ42 and the onset of Alzheimer’s Disease

    Authors: , , , - Ageing Research Reviews 2023 cited by 26

  17. Targeted Disruption of Mouse EGF receptor: Effect of Genetic Background on Mutant Phenotype

    Authors: , , , , , , , , , , , , , - Science 1995 cited by 1,475

  18. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?

    Authors: , - Nature reviews. Neuroscience 2007 cited by 506

  19. Reimagining Alzheimer's Disease—An Age-Based Hypothesis

    Authors: - Journal of Neuroscience 2010 cited by 405

  20. Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte‐derived lipid transport

    Authors: , , , , , , - Journal of Neurochemistry 2022 cited by 33

  21. Re‐imagining Alzheimer's disease – the diminishing importance of amyloid and a glimpse of what lies ahead

    Authors: , - Journal of Neurochemistry 2017 cited by 110

  22. The Control of Neuron Number

    Authors: , - Annual Review of Neuroscience 1988 cited by 577

  23. Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease

    Authors: , , - Journal of Neuroscience 2003 cited by 480

  24. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia

    Authors: , , , , , , - Nature Medicine 2012 cited by 222